PubRank

D A Rowley

Author PubWeight™ 84.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of 'free' iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem J 1981 2.68
2 The specific selection of recirculating lymphocytes by antigen in normal and preimmunized rats. J Exp Med 1972 2.66
3 The rate of division of antibody-forming cells during the early primary immune response. J Exp Med 1968 2.10
4 Homeostasis of the antibody response: immunoregulation by NK cells. Science 1983 2.04
5 A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc Natl Acad Sci U S A 1990 2.03
6 Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection. Proc Natl Acad Sci U S A 1995 1.94
7 Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells. J Exp Med 1992 1.81
8 Superoxide-dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Detection of 'catalytic' iron and anti-oxidant activity in extracellular fluids. Biochem J 1982 1.72
9 Dendritic cells that have interacted with antigen are targets for natural killer cells. J Exp Med 1985 1.68
10 Specific suppression of immune responses. Science 1973 1.67
11 Neonatal tolerance induced by antibody against antigen-specific receptor. Science 1974 1.61
12 Cellular deficit in thymectomized mice. Nature 1970 1.57
13 Suppression by autogenous complementary idiotypes: the priority of the first response. J Exp Med 1976 1.43
14 Hypersensitivity: specific immunologic suppression of the delayed type. Science 1968 1.42
15 Ultrastructure of antibody-forming cells. Nature 1965 1.42
16 The immune response suppressed by specific antibody. Immunology 1969 1.38
17 Unique tumor-specific antigens. Annu Rev Immunol 1988 1.33
18 Suppression of tumor rejection by autologous anti-idiotypic immunity. Proc Natl Acad Sci U S A 1980 1.28
19 Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance. Cancer Res 1990 1.28
20 Superoxide-dependent formation of hydroxyl radicals in the presence of thiol compounds. FEBS Lett 1982 1.27
21 Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci (Lond) 1985 1.27
22 Cell respiration as a requirement for antibody release in vitro. Nature 1968 1.21
23 Reactions of ferrioxamine and desferrioxamine with the hydroxyl radical. Chem Biol Interact 1982 1.20
24 Anti-receptor antibody. II. Induction of long-term unresponsiveness in neonatal mice. J Immunol 1975 1.19
25 Formation of hydroxyl radicals from hydrogen peroxide and iron salts by superoxide- and ascorbate-dependent mechanisms: relevance to the pathology of rheumatoid disease. Clin Sci (Lond) 1983 1.17
26 Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals in the presence of copper salts: a physiologically significant reaction? Arch Biochem Biophys 1983 1.14
27 Multiple cancers. Tumor burden permits the outgrowth of other cancers. J Exp Med 1985 1.13
28 Superoxide-dependent formation of hydroxyl radicals from NADH and NADPH in the presence of iron salts. FEBS Lett 1982 1.13
29 Enhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoprotein. J Exp Med 2000 1.12
30 Portable infrared pupillometry using Pupilscan: relation to somatic and autonomic nerve function in diabetes mellitus. Clin Auton Res 1992 1.11
31 The third cell type required for the immune response of spleen cells in vitro. J Immunol 1971 1.09
32 Immune response to phosphorylcholine. III. Requirement of the Fc portion and equal effectiveness of IgG subclasses in anti-receptor antibody-induced suppression. J Immunol 1977 1.08
33 A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens. J Exp Med 1993 1.07
34 NK cells suppress the generation of Lyt-2+ cytolytic T cells by suppressing or eliminating dendritic cells. J Immunol 1986 1.05
35 An immunologic network. Contemp Top Immunobiol 1980 1.04
36 Immunological enhancement of primary tumor development and its prevention. Semin Cancer Biol 2000 1.00
37 CD4+ and B lymphocytes in transplantation immunity. II. Augmented rejection of tumor allografts by mice lacking B cells. Transplantation 1993 0.99
38 Heart rates during 24 hours of usual activity for 100 normal men. J Appl Physiol 1970 0.98
39 Antibody-dependent cell-mediated cytotoxicity. I. Differentiation from antibody-independent cytotoxicity by "normal" IgG. J Immunol 1974 0.96
40 DNA damage by superoxide-generating systems in relation to the mechanism of action of the anti-tumour antibiotic adriamycin. Biochim Biophys Acta 1983 0.94
41 Quantitative measures of sympathetic skin response in diabetes: relation to sudomotor and neurological function. J Neurol Neurosurg Psychiatry 1992 0.94
42 Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytes. Eur J Immunol 1993 0.93
43 Do antibody-forming cells circulate in the blood? J Immunol 1969 0.91
44 Presence of both cell-mediated immunity and serum-blocking factors in rat renal allografts "enhanced" by passive immunization. Transplantation 1971 0.90
45 Specific suppression of renal allograft rejection by treatment with antigen and antibody. Transplant Proc 1970 0.90
46 Measurement of Human Heart Rate during Usual Activty. Science 1959 0.89
47 Specific suppression of the antibody response in vitro by serum from paralyzed mice. J Immunol 1975 0.87
48 Thy-1+ and Thy-1- natural killer cells. Only Thy-1- natural killer cells suppress dendritic cells. J Exp Med 1986 0.87
49 Mechanism of action of nitroimidazole antimicrobial and antitumour radiosensitizing drugs. Effects of reduced misonidazole on DNA. Int J Radiat Biol Relat Stud Phys Chem Med 1979 0.87
50 Immunoregulation by natural killer cells. Cell Immunol 1986 0.86
51 Cytokines and cancer: experimental systems. Curr Opin Immunol 1991 0.86
52 Specific antigens inhibit plasmacytoma cells bearing phosphorylcholine-binding myeloma proteins. Cell Immunol 1978 0.85
53 Increased non-protein-bound iron and decreased protection against superoxide-radical damage in cerebrospinal fluid from patients with neuronal ceroid lipofuscinoses. Lancet 1982 0.85
54 Time-dependent resistance or susceptibility of tumor cells to cytotoxic antibody after exposure to a chemotherapeutic agent. Proc Natl Acad Sci U S A 1978 0.83
55 Highly immunogenic regressor tumor cells can prevent development of postsurgical tumor immunity. Cell Immunol 1989 0.82
56 A comparison of murine hepatic accessory cells and splenic dendritic cells. Cell Immunol 1989 0.82
57 Reduced chloramphenicol-induced damage to DNA. J Antimicrob Chemother 1981 0.82
58 Assessment of basal and stimulated sweating in diabetes using a direct-reading computerized sudorometer. Diabet Med 1991 0.82
59 Formation of hydroxyl radicals from NADH and NADPH in the presence of copper salts. J Inorg Biochem 1985 0.81
60 Complementary idiotypy in the regulation of the immune response. Fed Proc 1977 0.81
61 The pattern of gene expression in mouse Gr-1(+) myeloid progenitor cells. Genomics 2001 0.81
62 Passive antibody delays development of cell-mediated immunity in rats receiving renal allografts. Transplant Proc 1973 0.80
63 Powerful immunosuppression mediated by interleukin 2-activated, nonantigen-specific, or H-2-restricted THY-1+ CD8+ cells. Cell Immunol 1989 0.80
64 Antibody against the antigen receptor of a plasmacytoma prolongs survival of mice bearing the tumor. J Immunol 1976 0.80
65 Cellular and humoral immunity after allogeneic transplantation in the rat. 3. The effect of passive antibody on cellular and humoral immunity after allogeneic renal transplantation. Transplantation 1973 0.80
66 The effect of nitroheterocyclic drugs on DNA: an in vitro model of cytotoxicity. Biochem Pharmacol 1979 0.80
67 Cellular and humoral immunity after allogeneic transplantation in the rat. II. Comparison of a 51Cr release assay and modified microcytotoxicity assay for detection of cellular immunity and blocking serum factors. Transplantation 1973 0.79
68 Copper and iron complexes catalytic for oxygen radical reactions in sweat from human athletes. Clin Chim Acta 1985 0.79
69 The relationship between misonidazole cytotoxicity and base composition of DNA. Biochem Pharmacol 1980 0.79
70 Changes in cholinergic sweat gland activation in diabetic neuropathy identified by computerised sweatspot analysis. Diabetologia 1991 0.79
71 CD4-positive and B lymphocytes in transplantation immunity. I. Promotion of tumor allograft rejection through elimination of CD4-positive lymphocytes. Transplantation 1993 0.78
72 Regulation by complementary idiotypes. Ig protects the clone producing it. J Exp Med 1981 0.77
73 The liver of MRL/lpr mice contains defective accessory cells and a population of immunosuppressive lymphocytes. Cell Immunol 1990 0.77
74 Simultaneous complementary idiotypic responses: absence of reciprocal regulation. J Exp Med 1978 0.76
75 Specific suppression of cell-mediated immune responses. Transplant Proc 1969 0.75
76 Cardiotachometer. Science 1960 0.75
77 Development of a fiber-optic sensor for trace metal detection in aqueous environments. Appl Opt 1993 0.75
78 Cellular and humoral immunity after allogeneic transplantation in the rat. IV. The effect of heterologous antilymphocyte serum on cellular and humoral immunity after allogeneic renal transplantation. Transplantation 1973 0.75